Korean J Physiol Pharmacol.
1998 Apr;2(2):185-192.
A role of endogenous somatostatin in exocrine secretion induced by intrapancreatic cholinergic activation
- Affiliations
-
- 1Department of Physiology, College of Medicine, Hallym University, Chunchon 200-702, Kangwon-Do, Korea.
- 2Department of Anatomy, College of Medicine, Inha University, Inchon 402-751, Korea.
Abstract
-
A role of endogenous somatostatin in pancreatic exocrine secretion
induced by intrapancreatic cholinergic activation was studied in the
isolated rat pancreas perfused with modified Krebs-Henseleit solution.
Intrapancreatic neurons were activated by electrical field stimulation
(EFS: 15 V, 2 msec and 8 Hz). Pancreatic exocrine secretion, including
volume flow and amylase output, and release of somatostatin from the
pancreas were respectively determined. Somatostatin cells in the islet
were stained with an immunoperoxidase method. EFS significantly
increased pancreatic volume flow and amylase output, which were reduced
by atropine by 59% and 78%, respectively. Intraarterial infusion of
either pertussis toxin or a somatostatin antagonist resulted in a
further increase in the EFS-evoked pancreatic secretion. EFS also
further elevated exocrine secretion in the pancreas treated with
cysteamine, which was completely restored by intraarterial infusion of
somatostatin. EFS significantly increased not only the number of
immunoreactive somatostatin cells in the islet but also the
concentration of immunoreactive somatostatin in portal effluent. It is
concluded from the above results that intrapancreatic cholinergic
activation elevates pancreatic exocrine secretion as well as release of
endogenous somatostatin. Endogenous somatostatin exerts an inhibitory
influence on exocrine secretion induced by intrapancreatic cholinergic
activation via the islet-acinar portal system in the isolated pancreas
of the rat.